ask_amy_jan_pV6.qxp Ask the audit specialist ...
author: rob.schlissberg
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, TACARYL to ZYPREXA Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS TACARYL to ZYPREXA Trade Name Generic TACARYL Methdilazine TACE Chlorotrianisene TAGAMET Cimetidine TALWIN *Pentazocine TAMBOCOR Flecainide TAMIFLU Oseltamivir TAPAZOLE Methimazole TASMAR Tolcapone TAVIST Clemastine TAXOL Paclitaxel TAZICEF Ceftazidime TAZIDIME Ceftazidime TEGISON Etretinate...
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs. Salmeterol to Zolpidem Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Salmeterol to Zolpidem Generic Trade Name Salmeterol SEREVENT Salsalate DISALCID, SALFLEX Saquinavir FORTOVASE Sargramostim LEUKINE Secobarbital SECONAL Selegiline ELDEPRYL Selenium SELSUN Sertraline ZOLOFT Sibutramine MERIDIA Sildenafil VIAGRA Silver sulfadiazine SILVADENE Simethicone MYLICON...
Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library Topic Contents - Examples - How It Works - Why It Is Used - How Well It Works - Side Effects - What To Think About - References Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library Triptans (serotonin receptor agonists) for migraine headaches - [Medication] - Quest Diagnostics Patient Health Library Brain and nerves,...
Sumatriptan for cluster headaches - [Medication] - Quest Diagnostics Patient Health Library Sumatriptan for cluster headaches Examples Brand Name Chemical Name Imitrex sumatriptan succinate The injected form of sumatriptan is used to treat cluster headaches.
AstraZeneca - merger partners, Astra AB, Zeneca Group PLC Skip to content Home Media Investors Careers Products Licensing Research Responsibility About us A video introduction to AstraZeneca Key facts Board & management People culture & values Meeting customer needs Worldwide locations History - Merger partners in brief - Our track record Contact us Home - - About us - - History - -Merger partners in brief - - Merger partners in brief Astra...
AstraZeneca International - pharmaceutical company, prescription drugs, medicine manufacturers Skip to content Home Media Investors Careers Products Licensing Research Responsibility About us Contact us - - Zomig (zolmitriptan) Zomig (zolmitriptan) is an oral, selective 5-hydroxytryptamine1B/1D (5-HT1B/1D) receptor agonist or 'triptan' for acute treatment of migraine attacks with or without aura.
AstraZeneca International - pharmaceutical company, prescription drugs, medicine manufacturers Skip to content Home Media Investors Careers Products Licensing Research Responsibility About us Contact us - - Neuroscience Health problems related to the function of the nervous system, including the brain, are a complex area of significant medical need that touches many people's lives.
AstraZeneca Products - Drug information, prescription medicines, pharmaceuticals Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - -Products - - Products Our skills and resources are concentrated on six important areas of healthcare - representing the majority of the worldwide burden of disease.
ASTRAZENECA FILES NDA FOR ZOMIGA® (ZOLMITRIPTAN) - POTENTIALLY FIRST ORAL TRIPTAN IN JAPAN Skip to content Home Media Press releases - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 Corporate reports Facts, products, pipeline Image library Events calendar Media contacts Investors Careers Products Licensing Research Responsibility About us Contact us Home - - Media - - Press releases - -2000 - - function managePressContacts() { window.navigate("ncm.aspx?node=press");...
ASTRAZENECA FILES ZOMIGA® NASAL SPRAY IN EUROPE Skip to content Home Media Press releases - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 Corporate reports Facts, products, pipeline Image library Events calendar Media contacts Investors Careers Products Licensing Research Responsibility About us Contact us Home - - Media - - Press releases - -2000 - - function managePressContacts() { window.navigate("ncm.aspx?node=press");...
AstraZeneca - merger partners, Astra AB, Zeneca Group PLC Skip to content Home Media Investors Careers Products Licensing Research Responsibility About us A video introduction to AstraZeneca Key facts Board & management People culture & values Meeting customer needs Worldwide locations History - Merger partners in brief - Our track record Contact us Home - - About us - - History - -Merger partners in brief - - Merger partners in brief Astra...
Zomig (zolmitriptan) - Oral acute migraine treatment with or without aura Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - - Products - -Neuroscience - - Zomig, Zomig Rapimelt, Zomig Nasal Spray, AscoTop, Zomigon (zolmitriptan) Zomig (zolmitriptan) is an oral, selective 5-hydroxytryptamine 1B/1D...
AstraZeneca Products - Drug information, prescription medicines, pharmaceuticals Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - -Products - - Products Our skills and resources are concentrated on six important areas of healthcare - representing the majority of the worldwide burden of disease.
AstraZeneca Products - Drug information, prescription medicines, pharmaceuticals Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - -Products - - Products Our skills and resources are concentrated on six important areas of healthcare - representing the majority of the worldwide burden of disease.
AstraZeneca Products - Neuroscience - Schizophrenia, central nervous system, migraine treatments Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - - Products - -Neuroscience - - Neuroscience Health problems related to the function of the central nervous system, including the brain, are a complex area of significant...
AstraZeneca News - press release archive - pharmaceutical news - 2000 Skip to content Home Media Press releases - 2005 - 2004 - 2003 - 2002 - 2001 - 2000 - 1999 - 1998 Corporate reports Facts, products, pipeline Image library Events calendar Media contacts Investors Careers Products Licensing Research Responsibility About us Contact us Home - - Media - - Press releases - -2000 - - Press release archive 2000 20 December 2000 SENIOR APPOINTMENTS AT...
AstraZeneca Products - Drug information, prescription medicines, pharmaceuticals Skip to content Home Media Investors Careers Products Cardiovascular Gastrointestinal Infection Neuroscience Oncology Respiratory Non pharma businesses Licensing Research Responsibility About us Contact us Home - -Products - - Products Our skills and resources are concentrated on six important areas of healthcare - representing the majority of the worldwide burden of disease.
AstraZeneca Annual Report and Form 20-F 2000 -Key Product Summary Trade marks (compound name) / Main uses -Sales performance Gastrointestinal (GI) Losec/Prilosec (omeprazole) proton pump inhibitor (PPI) for acid related diseases (such as reflux oesophagitis) Losec MUPS (omeprazole) omeprazole in a tablet formulation Nexium (esomeprazole) PPI for acid related diseases (such as reflux oesophagitis) - - - - 2001 $m 2000 $m %...
AstraZeneca Financial Results 2003 Annual Review Key products: Gastrointestinal Losec/ Prilosec (omeprazole) proton pump inhibitor for acid related diseases Losec MUPS omeprazole in tablet form Nexium (esomeprazole) proton pump inhibitor for acid related diseases Key products: Infection Merrem/ Meronem 4 (meropenem) ultra broad spectrum injectable antibiotic for serious bacterial infection Key products: Cardiovascular Atacand 1 ...
BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through (4 Mar 02) - - - - BioNews BioWeb Companies Products BioReports - - - - - - BTECH REGULATORY RADAR - Tracking the Movement of Key Products Through (4 Mar 02) FDA APPROVED Sanofi-Synthelabo (Paris: SASY) and Bristol-Myers Squibb's (NYSE: BMY) Plavix (clopidogrel) label expanded The FDA approved Plavix for the acute coronary syndromes (ACS) known as unstable angina (chest pain) and non Q-wave...
BioPortfolio Limited Many companies could benefit from assessing their existing delivery technologies in other therapeutic areas, such as diabetes (needle-free injections, inhaled insulins), HRT (sustained-release patch technology) and others 10 CHAPTER 2 INTRODUCTION AND SCOPE 21 Disease overview 21 Etiology 21 Diagnosis and classification of migraine 22 Migraine diagnosis 22 Patient history and diaries...
AstraZeneca Annual Review 2004 Annual Review 2004 thinking people thinking performance AstraZeneca is one of the world's leading pharmaceutical companies.
duplicates:http://www.astrazeneca.com/sites/7/imagebank/typeArticleparam511562/astrazeneca-2004-annual-review.pdf
http://www.astrazeneca.com/sites/7/imagebank/typearticleparam511562/astrazeneca-2004-annual-report.pdf thinking performance AstraZeneca Annual Report and Form 20- F Information 2004 Annual Report and Form 20- F Information 2004 AstraZeneca Annual Report and Form 20- F Information 2004 Contents The Year in Brief 01 Dividend for 2004 01 Chairman's Statement 02 Chief Executive's Review 04 Global Market Overview 06 Financial Highlights 07 Board of Directors 08 Strategy 10 Key Products 10...
duplicates:http://www.astrazeneca.com/sites/7/imagebank/typeArticleparam511562/astrazeneca-2004-annual-report.pdf
7696v02_LR_Fact_1_28_05TP.qxp Cancer Arimidex (anastrozole) aromatase inhibitor for breast cancer Casodex (bicalutamide) anti- androgen for prostate cancer Faslodex (fulvestrant) oestrogen receptor antagonist with no agonist effects for breast cancer Iressa (gefitinib) signal transduction inhibitor for non- small cell lung cancer Nolvadex (tamoxifen) anti- oestrogen for breast cancer Zoladex (goserelin) LHRH...
author: Admin
